Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- Check3 days agoChange DetectedA new site revision label v3.6.2 was added and the previous v3.6.0 entry was removed from the history display.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', clarifying that the study is not enrolling. The revision label has updated to v3.6.0, with v3.5.5 removed.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page history now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page's metadata or rendering without altering core content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe Record History section now reflects a newer revision (v3.5.4) and no longer shows v3.5.3, indicating a page update to the version label.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s software/UI revision label is updated from `v3.5.2` to `v3.5.3`, indicating a minor technical release of the ClinicalTrials.gov interface rather than a modification to the underlying study record.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.0%

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.